ScholarIQanswers from OpenAlex & ORCID
Steven A. Rosenberg
ResearcherPublications, citations & collaboration network
Steven A. Rosenberg is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Steven A. Rosenberg have?
ScholarIQindexed works
Steven A. Rosenberg has 1,550 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Steven A. Rosenberg have?
ScholarIQcitation count
Steven A. Rosenberg has 199,067 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Steven A. Rosenberg?
ScholarIQh-index
Steven A. Rosenberg has an h-index of 219 in OpenAlex.
What is the i10-index of Steven A. Rosenberg?
ScholarIQi10-index
Steven A. Rosenberg has an i10-index of 893 in OpenAlex.
What is the ORCID of Steven A. Rosenberg?
ScholarIQorcid
The ORCID for Steven A. Rosenberg is on the source record.
What is the OpenAlex record for Steven A. Rosenberg?
ScholarIQopenalex
The OpenAlex for Steven A. Rosenberg is on the source record.
What are the most-cited papers on Steven A. Rosenberg?
ScholarIQmost cited works
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
Daniel W Lee, James N. Kochenderfer, Maryalice Stetler‐Stevenson, Yongzhi Cui, Cindy Delbrook, Steven A. Feldman, Terry J. Fry, Rimas J. Orentas, Marianna Sabatino, Nirali N. Shah, Seth M. Steinberg, D. Stroncek, Nick Tschernia, Constance M. Yuan, Hua Zhang, Ling Zhang, Steven A. Rosenberg, Alan S. Wayne, Crystal L. Mackall
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
Mark E. Dudley, John R. Wunderlich, Paul F. Robbins, James Chih‐Hsin Yang, Patrick Hwu, Douglas J. Schwartzentruber, Suzanne L. Topalian, Richard M. Sherry, Nicholas P. Restifo, Amy M. Hubicki, Michael R. Robinson, Mark Raffeld, Paul H. Duray, Claudia A. Seipp, Linda Rogers-Freezer, Kathleen E. Morton, Sharon Mavroukakis, Donald E. White, Steven A. Rosenberg
A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer
James Chih‐Hsin Yang, Leah Haworth, Richard M. Sherry, Patrick Hwu, Douglas J. Schwartzentruber, Suzanne L. Topalian, Seth M. Steinberg, Helen X. Chen, Steven A. Rosenberg
Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes
Richard A. Morgan, Mark E. Dudley, John R. Wunderlich, Marybeth S. Hughes, James Chih‐Hsin Yang, Richard M. Sherry, Richard E. Royal, Suzanne L. Topalian, Udai S. Kammula, Nicholas P. Restifo, Zhili Zheng, Azam Nahvi, Christiaan R. de Vries, Linda Rogers-Freezer, Sharon Mavroukakis, Steven A. Rosenberg
Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic Melanoma
Steven A. Rosenberg, Beverly S. Packard, Paul Aebersold, Diane Solomon, Suzanne L. Topalian, Stephen T. Toy, Paul Simon, Michael T. Lotze, James Chih‐Hsin Yang, Claudia A. Seipp, Colleen Simpson, Charles W. Carter, Steven Bock, Douglas J. Schwartzentruber, John P. Wei, Donald E. White